Regulatory and Compliance Updates news (page 16)

15 February 2026

Genentech's Gazyva Shows Positive Phase III Results in Primary Membranous Nephropathy

Phase III study shows Gazyva achieves significant remission in primary membranous nephropathy, with safety profile consistent and no new signals. Data to be shared with health authorities.
13 February 2026

EMA Recommends Withdrawal of Levamisole Medicines

Levamisole's risks, including leukoencephalopathy, outweigh benefits for treating parasitic infections. EMA advises EU market withdrawal due to safety concerns.
12 February 2026

European Industry Leaders Urge Action for Competitiveness and Sustainability

EU industry leaders stress urgent reforms to prevent job losses and closures, advocating for regulatory changes and investment to balance green goals with competitiveness.
12 February 2026

Stahl Achieves Early GIO Compliance for Food-Packaging Coatings

Stahl's food-packaging coatings meet GIO standards early, enhancing sustainability and offering customers regulatory-ready solutions for future compliance.
11 February 2026

Merck's KEYTRUDA and KEYTRUDA QLEX Approved for PD-L1+ Platinum-Resistant Ovarian Cancer

FDA approves KEYTRUDA regimens for platinum-resistant ovarian cancer, showing reduced disease progression and death risk in trials.
11 February 2026

ORLEN Acquires 25% Stake in Afrodite Gas Discovery

ORLEN acquires 25% of PL293 in the North Sea, targeting 1.9 bcm of gas. The project tests new production methods and aligns with ORLEN's strategy for Norwegian gas development by 2030.

The right choices in the European chemical industry

Save time with chemXplore Alpha

Learn more

← Previous Next →